These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 788759)

  • 21. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
    Crisp AJ; Kennedy PG; Hoffbrand BI; Ebbutt AF; Carruthers M
    Curr Med Res Opin; 1980; 7(2):101-3. PubMed ID: 7002477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclothiazide and atenolol once daily in essential hypertension.
    Pitkäjärvi T
    Ann Clin Res; 1979 Feb; 11(1):1-8. PubMed ID: 378090
    [No Abstract]   [Full Text] [Related]  

  • 23. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
    Barnett AJ; Kalowski S; Guest C
    Med J Aust; 1978 Jan; 1(2):105-9. PubMed ID: 349319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice study.
    Forrest WA
    Br J Clin Pract; 1973 Sep; 27(9):331-5. PubMed ID: 4595072
    [No Abstract]   [Full Text] [Related]  

  • 27. The treatment of hypertension in older patients: a double-blind, between-patient study, in previously treated patients comparing a diuretic, a beta-receptor antagonist, and their fixed combination.
    Forrest WA
    J Int Med Res; 1981; 9(6):490-4. PubMed ID: 7033014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
    Forrest WA; Bridgman KM; Ebbutt AF
    Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
    [No Abstract]   [Full Text] [Related]  

  • 29. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
    Forrest WA
    Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
    [No Abstract]   [Full Text] [Related]  

  • 30. Hydralazine and oxprenolol in the treatment of hypertension and the effect of these drugs on plasma renin activity.
    Siitonen L
    J Int Med Res; 1980; 8(3):181-7. PubMed ID: 6993250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrallazine and beta-blockade in refractory hypertension with characterization of acetylator phenotype.
    Hunyor SN
    Aust N Z J Med; 1975 Dec; 5(6):530-6. PubMed ID: 7224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1977 Sep; 14(3):163-97. PubMed ID: 143363
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
    Levenstein JH
    S Afr Med J; 1978 Nov; 54(21):860-4. PubMed ID: 371021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of captopril, hydralazine and nifedipine as third drug in hypertensive patients.
    Bevan EG; Pringle SD; Waller PC; Herrick AL; Findlay JG; Murray GD; Carmichael HA; Reid JL; Weir RJ; Lorimer AR
    J Hum Hypertens; 1993 Feb; 7(1):83-8. PubMed ID: 8095558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Approach to drug therapy for hypertension.
    Kuchel OG; Mahon WA; McKenzie JK; Ogilvie RI
    Can Med Assoc J; 1979 Mar; 120(5):565-70. PubMed ID: 35278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 38. Prazosin in hypertension. Clinical studies with special reference to initiation of therapy.
    Turner AS; Watson OF; Brocklehurst JE
    Med J Aust; 1977 Aug; 2(2 Suppl):33-7. PubMed ID: 21343
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension.
    Wray R; Benton KG; Whitehill D; Wright B; Weener W; Whittington JR
    Curr Med Res Opin; 1983; 8(9):665-74. PubMed ID: 6365467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hypertension successively with a diuretic, clonidine or a beta-blocking agent and hydralazine.
    Pitkäjärvi T; Ala-Laurila P; Ruosteenoja R; Torsti P; Masar SE
    Eur J Clin Pharmacol; 1977 Nov; 12(3):161-5. PubMed ID: 590301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.